Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer
October 22, 2020 06:00 ET
|
Genetron Holdings Limited
BEIJING, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health Receives U.S. FDA Breakthrough Device Designation for its Blood-based NGS Test for Early Detection of Hepatocellular Carcinoma
September 30, 2020 08:11 ET
|
Genetron Holdings Limited
BEIJING and GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China...
Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib
September 25, 2020 06:00 ET
|
Genetron Holdings Limited
BEIJING and SUZHOU, China, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Highlight Data from 18 Studies at ESMO 2020
September 18, 2020 06:00 ET
|
Genetron Holdings Limited
Genetron Health to present data at ESMO 2020 relating to precision oncology diagnostic development initiatives across lung, gastrointestinal and other cancer types, and to bioinformatics development ...
Genetron Health and dMed Announce Partnership Agreement
September 16, 2020 17:00 ET
|
Genetron Holdings Limited
BEIJING, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health to Present at Upcoming Investor Conferences
September 08, 2020 16:15 ET
|
Genetron Holdings Limited
BEIJING, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System Cancers
August 29, 2020 10:32 ET
|
Genetron Holdings Limited
BEIJING, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health Reports Second Quarter 2020 Unaudited Financial Results
August 06, 2020 06:30 ET
|
Genetron Holdings Limited
BEIJING, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
Genetron Health to Present at Canaccord Genuity 40th Annual Growth Conference
July 29, 2020 16:39 ET
|
Genetron Holdings Limited
BEIJING, July 29, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
Genetron Health to Announce Second Quarter Unaudited Financial Results and Host Investor Call on August 6, 2020
July 27, 2020 16:30 ET
|
Genetron Holdings Limited
BEIJING, July 27, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology company in China that specializes in offering...